FDA approves expanded use of Jazz Pharma's sleep disorder drug Xywav

FDA approves expanded use of Jazz Pharma's sleep disorder drug Xywav

Submitted by admin on August 12, 2021 - 10:54pm
Source: 
Yahoo/Reuters
News Tags: 
Jazz Pharmaceuticals
Xywav
FDA
idiopathic hypersomnia
Headline: 
FDA approves expanded use of Jazz Pharma's sleep disorder drug Xywav
snippet: 

Jazz Pharmaceuticals PLC said on Thursday its sleep disorder drug Xywav received U.S. regulatory approval for the expanded use in patients suffering from excessive daytime sleepiness despite a good night's sleep.

Do Not Allow Advertisers to Use My Personal information